Show
Sort by
-
An integrated paediatric population PK/PD analysis of dDAVP : how do PK differences translate to clinical outcomes?
-
A semi-mechanistic population pharmacokinetic/pharmacodynamic model of bortezomib in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
-
- Journal Article
- A1
- open access
Vancomycin pharmacokinetics throughout life : results from a pooled population analysis and evaluation of current dosing recommendations
-
A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients
-
- Journal Article
- A1
- open access
Clinical pharmacokinetics and pharmacodynamics of propofol
-
- Journal Article
- A1
- open access
Target-controlled continuous infusion for antibiotic dosing : proof-of-principle in an in-silico vancomycin trial in intensive care unit patients
-
- Journal Article
- A1
- open access
Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine
-
Scientific rationale for determining the bioequivalence of inhaled drugs
-
Population pharmacokinetics of a novel once-every 3 months intramuscular formulation of paliperidone palmitate in patients with schizophrenia
-
Modeling the relationship between exposure to abiraterone and prostate-specific antigen dynamics in patients with metastatic castration-resistant prostate cancer